{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:05:09Z","timestamp":1789988709795,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2024.03.025","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:02:38Z","timestamp":1710475358000},"page":"2661-2671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adverse events following immunisation: Prospective cohort study evaluating Australian children presenting to specialist immunisation clinics"],"prefix":"10.1016","volume":"42","author":[{"given":"Hannah","family":"Stubbs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-4051","authenticated-orcid":false,"given":"Pamela","family":"Palasanthiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Koirala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Duguid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidre","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3111-5586","authenticated-orcid":false,"given":"Rama","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.03.025_b0005","doi-asserted-by":"crossref","first-page":"e2416","DOI":"10.1002\/rmv.2416","article-title":"Safety of varicella vaccination strategies: an overview of reviews","volume":"33","author":"Ahern","year":"2023","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2024.03.025_b0010","unstructured":"Australian Institute of Health and Welfare. The burden of vaccine preventable diseases in Australia. Canberra: Australian Institute of Health and Welfare; 2019."},{"key":"10.1016\/j.vaccine.2024.03.025_b0015","unstructured":"World Health Organization. Immunization Agenda 2030: A Global Strategy to Leave No One Behind. Geneva: World Health Organization; 2020."},{"key":"10.1016\/j.vaccine.2024.03.025_b0020","doi-asserted-by":"crossref","first-page":"B61","DOI":"10.1016\/j.vaccine.2012.11.035","article-title":"The estimated mortality impact of vaccinations forecast to be administered during 2011\u20132020 in 73 countries supported by the GAVI Alliance","volume":"31","author":"Lee","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.03.025_b0025","unstructured":"Department of Health and Aged Care. National Immunisation Strategy for Australia 2019 - 2024. In: Department of Health and Aged Care, editor. Canberra: Australian Government; 2018."},{"key":"10.1016\/j.vaccine.2024.03.025_b0030","unstructured":"Department of Health and Aged Care. National Immunisation Program Schedule. In: Department of Health and Aged Care, editor. Canberra: Australian Government; 2023."},{"key":"10.1016\/j.vaccine.2024.03.025_b0035","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. COVID-19, https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccine-preventable-diseases\/covid-19; 2022 [accessed 26 June 2023]."},{"key":"10.1016\/j.vaccine.2024.03.025_b0040","doi-asserted-by":"crossref","unstructured":"Hull B, Hendry A, Dey A, Brotherton J, Macartney K, Beard F. Annual immunisation coverage report, 2021. Commun Dis Intell. 2023;47:10.33321\/cdi.2023.47.47.","DOI":"10.33321\/cdi.2023.47.47"},{"key":"10.1016\/j.vaccine.2024.03.025_b0045","doi-asserted-by":"crossref","unstructured":"Hull B, Hendry A, Dey A, Brotherton J, Macartney K, Beard F. Annual immunisation coverage report, 2020. Commun Dis Intell. 2022;46:10.33321\/cdi.2022.46.60.","DOI":"10.33321\/cdi.2022.46.60"},{"key":"10.1016\/j.vaccine.2024.03.025_b0050","doi-asserted-by":"crossref","unstructured":"Hull B, Hendry A, Dey A, Macartney K, Beard F. Immunisation Coverage Annual Report 2019. Commun Dis Intell. 2021;45:10.33321\/cdi.2021.45.18.","DOI":"10.33321\/cdi.2020.45.18"},{"key":"10.1016\/j.vaccine.2024.03.025_b0055","unstructured":"Vaccine Confidence Project. Australia, https:\/\/www.vaccineconfidence.org\/vci\/country\/au\/#classDfn; 2022 [accessed 19 December 2023]."},{"key":"10.1016\/j.vaccine.2024.03.025_b0060","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.03.025_b0065","doi-asserted-by":"crossref","first-page":"1101247","DOI":"10.3389\/falgy.2023.1101247","article-title":"COVID vaccine evaluation of barriers and resources among families of children with diagnosed allergies","volume":"4","author":"Gooding","year":"2023","journal-title":"Front Allergy"},{"key":"10.1016\/j.vaccine.2024.03.025_b0070","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00508-020-01777-9","article-title":"Towards understanding vaccine hesitancy and vaccination refusal in Austria","volume":"133","author":"Bauer","year":"2021","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.vaccine.2024.03.025_b0075","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s10995-021-03336-8","article-title":"Parents' behaviors and experiences associated with four vaccination behavior groups for childhood vaccine hesitancy","volume":"26","author":"Ellithorpe","year":"2022","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.vaccine.2024.03.025_b0080","unstructured":"World Health Organization. Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification second edition, 2019 update. 2 ed. Geneva: World Health Organization; 2019."},{"key":"10.1016\/j.vaccine.2024.03.025_b0085","doi-asserted-by":"crossref","unstructured":"Dey A, Wang H, Quinn H, Pillsbury A, Hickie M, Deng L, et al. Surveillance of adverse events following immunisation in Australia annual report, 2020. Commun Dis Intell. 2022;46:10.33321\/cdi.2022.46.47.","DOI":"10.33321\/cdi.2022.46.47"},{"key":"10.1016\/j.vaccine.2024.03.025_b0090","doi-asserted-by":"crossref","unstructured":"Clothier HJ, Lawrie J, Lewis G, Russell M, Crawford NW, Buttery JP. SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2018. Commun Dis Intell. 2020;44:10.33321\/cdi.2020.44.46.","DOI":"10.33321\/cdi.2020.44.46"},{"key":"10.1016\/j.vaccine.2024.03.025_b0095","series-title":"General best practice guidelines for immunization","author":"Kroger","year":"2023"},{"key":"10.1016\/j.vaccine.2024.03.025_b0100","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Preparing for vaccination, https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccination-procedures\/preparing-for-vaccination; 2023 [accessed 7 September 2023]."},{"key":"10.1016\/j.vaccine.2024.03.025_b0105","unstructured":"Report of the CIOMS\/WHO Working Group on Vaccine Pharmacovigilance. Definition and Application of Terms for Vaccine Pharmacovigilance. Geneva: Council for International Organizations of Medical Sciences; 2012."},{"key":"10.1016\/j.vaccine.2024.03.025_b0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-017-4083-4","article-title":"Active surveillance study of adverse events following immunisation of children in the Czech Republic","volume":"17","author":"Danova","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2024.03.025_b0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1071\/NB10041","article-title":"The role of the immunisation adverse events Clinic at the Children's Hospital at Westmead","volume":"21","author":"Wood","year":"2010","journal-title":"NSW Public Health Bull"},{"key":"10.1016\/j.vaccine.2024.03.025_b0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpeds.2022.07.019","article-title":"Revaccination and adverse event recurrence in patients with adverse events following immunization","volume":"250","author":"Mu\u00f1oz","year":"2022","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2024.03.025_b0125","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1097\/INF.0000000000001323","article-title":"Immunizing patients with adverse events after immunization and potential contraindications to immunization: a report from the special immunization clinics network","volume":"35","author":"Top","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.03.025_b0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/adc.83.2.128","article-title":"Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service","volume":"83","author":"Gold","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2024.03.025_b0135","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. After vaccination, https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccination-procedures\/after-vaccination; 2023 [accessed 19 December 2023]."},{"key":"10.1016\/j.vaccine.2024.03.025_b0140","unstructured":"World Health Organization. Global manual on surveillance of adverse events following immunization. 2016 update ed. Geneva: World Health Organization; 2014."},{"key":"10.1016\/j.vaccine.2024.03.025_b0145","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. extensive limb swelling, https:\/\/immunisationhandbook.health.gov.au\/technical-terms\/extensive-limb-swelling; 2018 [accessed 29 September 2023]."},{"key":"10.1016\/j.vaccine.2024.03.025_b0150","unstructured":"Australiasian society of clinical immunology and allergy. Acute Management of Anaphylaxis. Australiasian society of clinical immunology and allergy; 2023."},{"key":"10.1016\/j.vaccine.2024.03.025_b0155","doi-asserted-by":"crossref","unstructured":"Dey A, Wang H, Quinn H, Pillsbury A, Glover C, Hickie M, et al. Surveillance of adverse events following immunisation in Australia annual report, 2019. Commun Dis Intell. 2021;45:10.33321\/cdi.2021.45.23.","DOI":"10.33321\/cdi.2021.45.23"},{"key":"10.1016\/j.vaccine.2024.03.025_b0160","article-title":"Surveillance of adverse events following immunisation in Australia: annual report, 2018","volume":"44","author":"Dey","year":"2018","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2024.03.025_b0165","article-title":"Surveillance of adverse events following immunisation in Australia annual report, 2019","volume":"43","author":"Dey","year":"2017","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2024.03.025_b0170","unstructured":"Dey A, Wang H, Quinn H, Cook J, Macartney K. Surveillance of adverse events following immunisation in Australia report, 2016. Commun Dis Intell. 2018;42:S2209-6051(18)00011-8."},{"key":"10.1016\/j.vaccine.2024.03.025_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00948","article-title":"Vaccines safety in children and in general population: a pharmacovigilance study on adverse events following anti-infective vaccination in Italy","volume":"10","author":"Lombardi","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2024.03.025_b0180","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1016\/j.vaccine.2011.03.088","article-title":"Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4\u20136 years old","volume":"29","author":"Quinn","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.03.025_b0185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.15586\/aei.v49i1.32","article-title":"Revaccination following suspected vaccine-triggered hypersensitivity reactions: experience of a tertiary care Centre","volume":"49","author":"Ertugrul","year":"2021","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.vaccine.2024.03.025_b0190","doi-asserted-by":"crossref","unstructured":"Nicolosi L, Vittucci A, Mancini R, Bozzola E, Cagigi A, Grandin A, et al. Vaccine risk assessment in children with a referred reaction to a previous vaccine dose: 2009-2011 retrospective report at the Bambino Gesu' children hospital, Rome, Italy. Ital J Pediatr. 2014;40:10.1186\/824-7288-40-31.","DOI":"10.1186\/1824-7288-40-31"},{"key":"10.1016\/j.vaccine.2024.03.025_b0195","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1440-1754.1999.00419.x","article-title":"Vaccination of children following a previous hypotonic-hyporesponsive episode","volume":"35","author":"Goodwin","year":"1999","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2024.03.025_b0200","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5694\/j.1326-5377.2011.tb04138.x","article-title":"Syncope and seizures following human papillomavirus vaccination: a retrospective case series","volume":"194","author":"Crawford","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2024.03.025_b0205","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3707","article-title":"Risk of recurrence of adverse events following immunization: a systematic review","volume":"140","author":"Zafack","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.03.025_b0210","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/INF.0000000000002162","article-title":"Rate of recurrence of adverse events following immunization: results of 19 years of surveillance in Quebec","volume":"38","author":"Zafack","year":"2019","journal-title":"Canada Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.03.025_b0215","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.vaccine.2021.02.016","article-title":"Revaccination outcomes of children with vaccine proximate seizures","volume":"39","author":"Deng","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.03.025_b0220","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026953","article-title":"Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in european randomised controlled trials","volume":"9","author":"Zafack","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2024.03.025_b0225","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults","volume":"137","author":"McNeil","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2024.03.025_b0230","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1080\/21645515.2018.1460293","article-title":"Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria","volume":"14","author":"Baxter","year":"2018","journal-title":"Australia Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.03.025_b0235","first-page":"1996","article-title":"VAERS Working group. hypotonic-hyporesponsive episodes reported to the vaccine adverse event reporting system (VAERS)","volume":"106","author":"DuVernoy","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.03.025_b0240","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/INF.0b013e31816591f7","article-title":"Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose","volume":"27","author":"Rennels","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.03.025_b0245","article-title":"Safety of co-administration versus separate Administration of the Same Vaccines in children: a systematic literature review","volume":"8","author":"Bauwens","year":"2020","journal-title":"Vaccines (Basel)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T10:05:58Z","timestamp":1712138758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24003128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0264410X24003128"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events following immunisation: Prospective cohort study evaluating Australian children presenting to specialist immunisation clinics","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}